Stanford uses CRISPR to correct sickle cell, human trials planned

CHICAGO (Reuters) – Scientists at Stanford University School of Medicine have used the CRISPR gene editing tool to repair the gene that causes sickle cell disease in stem cells from diseased patients, paving the way for a potential cure for the disease, which affects up to 5 million people globally.


Source: Reuters Health